» Articles » PMID: 39001591

'Hot Phase' Non-dilated Left Ventricular Cardiomyopathy with Atypical Onset and Recurrence: a Case Report

Overview
Journal ESC Heart Fail
Date 2024 Jul 13
PMID 39001591
Authors
Affiliations
Soon will be listed here.
Abstract

Non-dilated left ventricular cardiomyopathy (NDLVC) is a newly categorized cardiomyopathy phenotype includingseveral aetiologies with a linking characteristic represented by the normal left ventricular volume. Inflammatory heart disease (InHD) is a heterogeneous process with variegate clinical manifestations, sometimes in overlap with NDLVC. A 26-year-old woman was admitted forcomplete heart block (CHB) and persistently raised troponin. Echocardiography and coronary angiography were normal. Extensive oedema and late gadolinium enhancement was found at cardiac magnetic resonance. Endomyocardial biopsy showed no signs of active myocarditis. Steroid therapy was started with restoration of atrioventricular conduction but subsequently the patient experienced a mild recurrence with a new troponin relapse. Genetic test was negative for mutations related with the clinical scenario. In this case of NDLVC with InHD the precise diagnostic work-up, including genetic test, was crucial for diagnostic, prognostic andtherapeutic purposes. Multimodality approach is crucial to detect and treat possible recurrences.

Citing Articles

Hot Phases Cardiomyopathy: Pathophysiology, Diagnostic Challenges, and Emerging Therapies.

Bassetto G, Angriman F, Pio Loco Detto Gava C, Paldino A, Perotto M, Bordignon L Curr Cardiol Rep. 2025; 27(1):11.

PMID: 39786662 PMC: 11717892. DOI: 10.1007/s11886-024-02168-6.


'Hot phase' non-dilated left ventricular cardiomyopathy with atypical onset and recurrence: a case report.

Gonano N, Nuzzi V, Pavan D, Piazza R, Pecoraro R, Altinier A ESC Heart Fail. 2024; 11(6):4407-4412.

PMID: 39001591 PMC: 11631281. DOI: 10.1002/ehf2.14822.

References
1.
Lazzerini P, Ginjupalli V, Srivastava U, Bertolozzi I, Bacarelli M, Verrengia D . Anti-Ro/SSA Antibodies Blocking Calcium Channels as a Potentially Reversible Cause of Atrioventricular Block in Adults. JACC Clin Electrophysiol. 2023; 9(8 Pt 3):1631-1648. DOI: 10.1016/j.jacep.2023.03.007. View

2.
Bariani R, Cipriani A, Rizzo S, Celeghin R, Bueno Marinas M, Giorgi B . 'Hot phase' clinical presentation in arrhythmogenic cardiomyopathy. Europace. 2020; 23(6):907-917. PMC: 8184227. DOI: 10.1093/europace/euaa343. View

3.
Chimenti C, Russo M, Frustaci A . Immunosuppressive therapy in virus-negative inflammatory cardiomyopathy: 20-year follow-up of the TIMIC trial. Eur Heart J. 2022; 43(36):3463-3473. PMC: 9492235. DOI: 10.1093/eurheartj/ehac348. View

4.
Peretto G, Casella M, Merlo M, Benedetti S, Rizzo S, Cappelletto C . Inflammation on Endomyocardial Biopsy Predicts Risk of MACE in Undefined Left Ventricular Arrhythmogenic Cardiomyopathy. JACC Clin Electrophysiol. 2023; 9(7 Pt 1):951-961. DOI: 10.1016/j.jacep.2022.10.032. View

5.
Smith E, Lakdawala N, Papoutsidakis N, Aubert G, Mazzanti A, McCanta A . Desmoplakin Cardiomyopathy, a Fibrotic and Inflammatory Form of Cardiomyopathy Distinct From Typical Dilated or Arrhythmogenic Right Ventricular Cardiomyopathy. Circulation. 2020; 141(23):1872-1884. PMC: 7286080. DOI: 10.1161/CIRCULATIONAHA.119.044934. View